Stockholder alert: robbins llp informs investors of the novo nordisk a/s class action

San diego , jan. 27, 2025 /prnewswire/ -- robbins llp informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired novo nordisk a/s (nyse: nvo) securities between november 2, 2022 and december 19, 2024. novo is a healthcare company, focused on the research, development, manufacturing, and distribution of pharmaceutical productions globally.
NVO Ratings Summary
NVO Quant Ranking